The MEDICREA Group announced group sales results for the fourth quarter and year 2016. For the fourth quarter, the company’s sales increased 13%, to €7.8 million from €6.9 million for the same period of 2015, in line with the accelerated adoption of Medicrea’s patient-specific UNiD™ technology, notably in the United States where for the entire year the number of surgeries performed with personalized rods implants have increased by 106% compared to 2015. For the year, the group sales reached a total of €29.4 million in 2016, generating a 6% growth compared €27.8 million for the previous year.